V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Market Cap: 10.8B CHF
Have any thoughts about
Vifor Pharma AG?
Write Note

Vifor Pharma AG
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Interest Income Expense Peer Comparison

Comparables:
NOVN
ROG
S
SDZ

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Interest Income Expense
CHf30.6m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Novartis AG
SIX:NOVN
Interest Income Expense
-$982m
CAGR 3-Years
N/A
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Roche Holding AG
SIX:ROG
Interest Income Expense
-CHf893m
CAGR 3-Years
-26%
CAGR 5-Years
-16%
CAGR 10-Years
6%
S
Sandoz Group AG
SIX:SDZ
Interest Income Expense
-$225m
CAGR 3-Years
-37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Interest Income Expense?
Interest Income Expense
30.6m CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Interest Income Expense amounts to 30.6m CHF.

What is Vifor Pharma AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
-14%

The average annual Interest Income Expense growth rates for Vifor Pharma AG have been -14% over the past three years .

Back to Top